10-May-2024
Bristol Myers' Opdivo fails in Phase 3 lung cancer study
Seeking Alpha News (Fri, 10-May 5:13 PM ET)
Benzinga (Thu, 9-May 5:01 AM ET)
Globe Newswire (Wed, 8-May 8:30 AM ET)
AstraZeneca is withdrawing COVID shot worldwide due to vaccine glut
Seeking Alpha News (Wed, 8-May 7:06 AM ET)
UK Stocks: AstraZeneca (AZN) to Withdraw COVID Vaccine as Demand Wanes
TipRanks (Wed, 8-May 2:06 AM ET)
AstraZeneca Advances in Gene Therapy with Cellectis Stake
TipRanks (Tue, 7-May 7:57 AM ET)
AstraZeneca (AZN) Gets a Buy from Berenberg Bank
TipRanks (Tue, 7-May 1:25 AM ET)
Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
Globe Newswire (Mon, 6-May 2:00 AM ET)
Angle PLC Announces New Commercial Agreement with Large Pharma
ACCESSWIRE (Fri, 3-May 2:06 AM ET)
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.
Astrazeneca PLC - American Depositary Shares trades on the NASDAQ stock market under the symbol AZN.
As of May 10, 2024, AZN stock price declined to $77.18 with 3,504,986 million shares trading.
AZN has a beta of 0.70, meaning it tends to be less sensitive to market movements. AZN has a correlation of 0.16 to the broad based SPY ETF.
AZN has a market cap of $239.12 billion. This is considered a Mega Cap stock.
Last quarter Astrazeneca PLC - American Depositary Shares reported $13 billion in Revenue and $1.03 earnings per share. This beat revenue expectation by $849 million and missed earnings estimates by -$.19.
In the last 3 years, AZN stock traded as high as $77.94 and as low as $52.65.
The top ETF exchange traded funds that AZN belongs to (by Net Assets): QQQ, QQQM, FVD, PPH, DFIC.
AZN stock has underperformed the market in the last year with a return of +5.0%, while SPY returned +27.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in AZN shares. However, AZN has outperformed the market in the last 3 month and 2 week periods, returning +25.5% and +2.7%, while SPY returned +4.2% and +2.5%, respectively. This indicates AZN has been having a stronger performance recently.
AZN support price is $76.76 and resistance is $78.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AZN stock will trade within this expected range on the day.